Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries.
Joris J KomenAnton PottegårdAukje K Mantel-TeeuwisseTomas ForslundPaul HjemdahlBjörn WettermarkMaja HellfritzschNina Sahlertz KristiansenMorten OlesenMarion BennieTanja MuellerAnnemarie VossTania SchinkUlrike HaugBianca KollhorstØystein KarlstadLars J KjerpesethOlaf H KlungelPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2022)
Persistence and adherence were high among NOAC users in five Western European healthcare settings and increased in later years. Dabigatran use was associated with slightly lower persistence and adherence compared with apixaban and rivaroxaban.